Variable | All variables model | Selected variables model | ||||
OR | 95% CI | P value | OR | 95% CI | P value | |
(Intercept) | 0.32 | 0.07 to 1.47 | 0.147 | 0.19 | 0.07 to 0.46 | <0.001 |
Age | ||||||
<65 | ||||||
≥65 | 2.27 | 1.03 to 5.16 | 0.044 | 2.88 | 1.50 to 5.73 | 0.002 |
Sex | ||||||
Female | ||||||
Male | 0.36 | 0.17 to 0.76 | 0.009 | |||
Race | ||||||
White | ||||||
Black | 0.69 | 0.26 to 1.77 | 0.440 | |||
Other | 0.55 | 0.24 to 1.27 | 0.167 | |||
NIHSS | ||||||
0–9 | ||||||
10–19 | 1.83 | 0.73 to 4.56 | 0.196 | |||
20–42 | 1.83 | 0.60 to 5.64 | 0.287 | |||
Atrial fibrillation | 2.38 | 0.99 to 5.96 | 0.057 | |||
Coronary artery disease | 1.88 | 0.72 to 4.99 | 0.200 | |||
Diabetes mellitus | 3.35 | 1.35 to 8.69 | 0.010 | |||
Dyslipidaemia | 0.74 | 0.34 to 1.60 | 0.450 | |||
Hypertension | 0.70 | 0.33 to 1.49 | 0.358 | |||
Obesity | 1.06 | 0.54 to 2.08 | 0.861 | |||
Previous stroke | 0.69 | 0.19 to 2.52 | 0.570 | |||
Smoker | 1.51 | 0.58 to 3.95 | 0.395 | |||
IV-tPA | 1.21 | 0.44 to 3.40 | 0.711 | |||
EVT | 0.43 | 0.16 to 1.14 | 0.095 | |||
Discharge mRS | ||||||
0–2 | ||||||
3–5 | 3.13 | 1.40 to 7.07 | 0.005 | 2.76 | 1.35 to 5.66 | 0.005 |
Discharge disposition | ||||||
IRF | ||||||
Home | 0.32 | 0.13 to 0.76 | 0.011 | 0.44 | 0.20 to 0.95 | 0.037 |
SNF | 2.29 | 0.75 to 8.08 | 0.164 | 3.62 | 1.35 to 5.66 | 0.005 |
LOS | ||||||
≤7 | ||||||
>7 | 3.72 | 1.63 to 8.70 | 0.002 | 2.99 | 1.49 to 6.05 | 0.002 |
Categories with empty OR, 95% CI and p value were the reference level in the model and p values were the reference level in the model.
EVT, endovascular therapy; IRF, Inpatient rehabilitation facility; IV-tPA, intravenous tissue-type plasminogen activator; LOS, length of stay; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SNF, skilled nursing facility.